Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss
by
Zhang, Hui
, Chintagumpala, Murali
, Gajjar, Amar
, Hassall, Tim
, Huang, Jie
, Gururangan, Sri
, Fisher, Michael
, Yamashita, Tetsuji
, Lim, Joshua Yew-Suang
, Onar-Thomas, Arzu
, Broniscer, Alberto
, Bass, Johnnie K
, Robinson, Giles W
, Cohn, Richard
, Zuo, Jian
, Yang, Jun J
, Stewart, Clinton F
, Bartels, Ute
, Xu, Heng
, Teitz, Tal
in
45
/ 45/43
/ 631/208/205/2138
/ 692/308/575
/ 692/699/67/1059/99
/ Acid Anhydride Hydrolases - genetics
/ Acylphosphatase
/ Age
/ Agriculture
/ Animal Genetics and Genomics
/ Antineoplastic Agents - adverse effects
/ Biomedicine
/ Brain cancer
/ Brain Neoplasms - drug therapy
/ Brain Neoplasms - enzymology
/ Brain Neoplasms - genetics
/ Brain research
/ Brain tumors
/ Cancer Research
/ Child, Preschool
/ Cisplatin
/ Cisplatin - adverse effects
/ Clinical Trials as Topic
/ Complications and side effects
/ Confidence intervals
/ Female
/ Free radicals
/ Gene Function
/ Genealogy
/ Genes
/ Genetic aspects
/ Genetic diversity
/ Genetic Predisposition to Disease
/ Genome-Wide Association Study - methods
/ Genomes
/ Genotype & phenotype
/ Hearing loss
/ Hearing Loss - chemically induced
/ Hearing Loss - enzymology
/ Hearing Loss - genetics
/ Human Genetics
/ Humans
/ Infant
/ letter
/ Male
/ Ototoxicity
/ Patients
/ Polymorphism, Single Nucleotide
/ Risk factors
/ Single nucleotide polymorphisms
/ Studies
/ Tumors
2015
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss
by
Zhang, Hui
, Chintagumpala, Murali
, Gajjar, Amar
, Hassall, Tim
, Huang, Jie
, Gururangan, Sri
, Fisher, Michael
, Yamashita, Tetsuji
, Lim, Joshua Yew-Suang
, Onar-Thomas, Arzu
, Broniscer, Alberto
, Bass, Johnnie K
, Robinson, Giles W
, Cohn, Richard
, Zuo, Jian
, Yang, Jun J
, Stewart, Clinton F
, Bartels, Ute
, Xu, Heng
, Teitz, Tal
in
45
/ 45/43
/ 631/208/205/2138
/ 692/308/575
/ 692/699/67/1059/99
/ Acid Anhydride Hydrolases - genetics
/ Acylphosphatase
/ Age
/ Agriculture
/ Animal Genetics and Genomics
/ Antineoplastic Agents - adverse effects
/ Biomedicine
/ Brain cancer
/ Brain Neoplasms - drug therapy
/ Brain Neoplasms - enzymology
/ Brain Neoplasms - genetics
/ Brain research
/ Brain tumors
/ Cancer Research
/ Child, Preschool
/ Cisplatin
/ Cisplatin - adverse effects
/ Clinical Trials as Topic
/ Complications and side effects
/ Confidence intervals
/ Female
/ Free radicals
/ Gene Function
/ Genealogy
/ Genes
/ Genetic aspects
/ Genetic diversity
/ Genetic Predisposition to Disease
/ Genome-Wide Association Study - methods
/ Genomes
/ Genotype & phenotype
/ Hearing loss
/ Hearing Loss - chemically induced
/ Hearing Loss - enzymology
/ Hearing Loss - genetics
/ Human Genetics
/ Humans
/ Infant
/ letter
/ Male
/ Ototoxicity
/ Patients
/ Polymorphism, Single Nucleotide
/ Risk factors
/ Single nucleotide polymorphisms
/ Studies
/ Tumors
2015
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss
by
Zhang, Hui
, Chintagumpala, Murali
, Gajjar, Amar
, Hassall, Tim
, Huang, Jie
, Gururangan, Sri
, Fisher, Michael
, Yamashita, Tetsuji
, Lim, Joshua Yew-Suang
, Onar-Thomas, Arzu
, Broniscer, Alberto
, Bass, Johnnie K
, Robinson, Giles W
, Cohn, Richard
, Zuo, Jian
, Yang, Jun J
, Stewart, Clinton F
, Bartels, Ute
, Xu, Heng
, Teitz, Tal
in
45
/ 45/43
/ 631/208/205/2138
/ 692/308/575
/ 692/699/67/1059/99
/ Acid Anhydride Hydrolases - genetics
/ Acylphosphatase
/ Age
/ Agriculture
/ Animal Genetics and Genomics
/ Antineoplastic Agents - adverse effects
/ Biomedicine
/ Brain cancer
/ Brain Neoplasms - drug therapy
/ Brain Neoplasms - enzymology
/ Brain Neoplasms - genetics
/ Brain research
/ Brain tumors
/ Cancer Research
/ Child, Preschool
/ Cisplatin
/ Cisplatin - adverse effects
/ Clinical Trials as Topic
/ Complications and side effects
/ Confidence intervals
/ Female
/ Free radicals
/ Gene Function
/ Genealogy
/ Genes
/ Genetic aspects
/ Genetic diversity
/ Genetic Predisposition to Disease
/ Genome-Wide Association Study - methods
/ Genomes
/ Genotype & phenotype
/ Hearing loss
/ Hearing Loss - chemically induced
/ Hearing Loss - enzymology
/ Hearing Loss - genetics
/ Human Genetics
/ Humans
/ Infant
/ letter
/ Male
/ Ototoxicity
/ Patients
/ Polymorphism, Single Nucleotide
/ Risk factors
/ Single nucleotide polymorphisms
/ Studies
/ Tumors
2015
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss
Journal Article
Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss
2015
Request Book From Autostore
and Choose the Collection Method
Overview
Jun Yang, Clinton Stewart and colleagues report the results of a genome-wide association study of cisplatin-induced ototoxicity among children undergoing treatment for brain tumors. They identify common variants in
ACYP2
strongly associated with cisplatin-induced hearing loss and ototoxicity severity.
Taking a genome-wide association study approach, we identified inherited genetic variations in
ACYP2
associated with cisplatin-related ototoxicity (rs1872328:
P
= 3.9 × 10
−8
, hazard ratio = 4.5) in 238 children with newly diagnosed brain tumors, with independent replication in 68 similarly treated children. The
ACYP2
risk variant strongly predisposed these patients to precipitous hearing loss and was related to ototoxicity severity. These results point to new biology underlying the ototoxic effects of platinum agents.
Publisher
Nature Publishing Group US,Nature Publishing Group
Subject
/ 45/43
/ Acid Anhydride Hydrolases - genetics
/ Age
/ Animal Genetics and Genomics
/ Antineoplastic Agents - adverse effects
/ Brain Neoplasms - drug therapy
/ Brain Neoplasms - enzymology
/ Complications and side effects
/ Female
/ Genes
/ Genetic Predisposition to Disease
/ Genome-Wide Association Study - methods
/ Genomes
/ Hearing Loss - chemically induced
/ Humans
/ Infant
/ letter
/ Male
/ Patients
/ Polymorphism, Single Nucleotide
/ Single nucleotide polymorphisms
/ Studies
/ Tumors
This website uses cookies to ensure you get the best experience on our website.